Mirae Asset Global Investments Co., Ltd.

Position in ABCL — AbCellera Biologics Inc.

CIK 1569395 SEOUL, M5

Position in ABCL

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$107,215

+$52,028 QoQ

Shares Held

13,658

-13.6% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#110

of 150 holders

Holding Since

Jun 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Mirae Asset Global Investments Co., Ltd. holds $279,047,947 across 206 Biotechnology names. ABCL ranks #76 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	210,209	$104,417,115
2	REGN	Regeneron Pharmaceuticals, Inc.	93,632	$58,383,296
3	ALNY	Alnylam Pharmaceuticals, Inc.	61,531	$18,522,675
4	MDGL	Madrigal Pharmaceuticals, Inc.	33,420	$17,944,868
5	ARGX	Argenx SE	11,164	$10,357,623
6	ONC	BeOne Medicines Ltd.	33,808	$9,634,265
7	RPRX	Royalty Pharma plc	150,556	$8,441,674
8	INCY	Incyte Corp	63,812	$7,233,728

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$107,215	13,658	-13.6%	Shares	Sole	2026-07-22
2026-03-31	$55,187	15,813	+8.7%	Shares	Sole	2026-05-04
2025-12-31	$49,747	14,546	+25.9%	Shares	Sole	2026-01-26
2025-09-30	$58,111	11,553	+0.2%	Shares	Sole	2025-11-03
2025-06-30	$39,547	11,530	+16.1%	Shares	Sole	2025-07-21
2025-03-31	$22,141	9,929	+0.9%	Shares	Sole	2025-04-24
2024-12-31	$28,839	9,843	-7.6%	Shares	Sole	2025-01-27
2024-09-30	$27,708	10,657	+21.4%	Shares	Sole	2024-10-23
2024-06-30	$25,985	8,779	-91.2%	Shares	Sole	2024-07-30
2024-03-31	$453,656	100,145	+1.6%	Shares	Defined	2024-05-01
2023-03-31	$743,066	98,550	-0.1%	Shares	Defined	2023-05-04
2022-12-31	$999,770	98,694	+6.3%	Shares	Sole	2023-02-09
2022-09-30	$918,533	92,875	+39.7%	Shares	Sole	2022-11-10
2022-06-30	$708,182	66,496	—	Shares	Sole	2022-08-15
No filing history on record for this holder in this stock.